PMID- 30904896 OWN - NLM STAT- MEDLINE DCOM- 20190723 LR - 20231011 IS - 1757-790X (Electronic) IS - 1757-790X (Linking) VI - 12 IP - 3 DP - 2019 Mar 22 TI - Chylous ascites in disseminated Kaposi sarcoma: an unusual manifestation as immune reconstitution inflammatory syndrome. LID - 10.1136/bcr-2018-228406 [doi] LID - e228406 AB - A 29-year-old man with diarrhoea, fever, abdominal pain and multiple purple papular lesions, neither pruriginous nor painful, was diagnosed with HIV-1 infection and disseminated Kaposi sarcoma (KS) with gastrointestinal involvement. He was started on highly active antiretroviral therapy immediately, as well as doxorubicin. Three weeks later, the patient developed bilateral moderate pleural effusion and large-volume ascites compatible with chylothorax and chylous ascites. An immune reconstitution inflammatory syndrome (IRIS) reaction was assumed. KS flare was associated with lymphatic obstruction and infiltration of thoracic duct by the tumour itself with leakage of chylous into pleural and peritoneal cavities. KS is the most common tumour in HIV patients and the existence of related effusions is not uncommon. KS-related chylothorax is an unusual manifestation of KS; there are only four cases described in the literature of chylous ascites related to KS-HIV. Overall survival is improving in KS but explosive and debilitating IRIS reactions can explain cases with poor prognosis. CI - (c) BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Cipriano, Patricia AU - Cipriano P AUID- ORCID: 0000-0002-0222-2171 AD - Department of Internal Medicine, Hospital de Cascais, Cascais, Portugal. FAU - Nabais, Ines AU - Nabais I AD - Department of Internal Medicine, Hospital de Cascais, Cascais, Portugal. FAU - Melo, Nuno AU - Melo N AD - Department of Internal Medicine, Hospital de Cascais, Cascais, Portugal. FAU - Alves, Ana Rafaela AU - Alves AR AD - Department of Internal Medicine, Hospital de Cascais, Cascais, Portugal. LA - eng PT - Case Reports PT - Journal Article DEP - 20190322 PL - England TA - BMJ Case Rep JT - BMJ case reports JID - 101526291 RN - 0 (liposomal doxorubicin) RN - 3WJQ0SDW1A (Polyethylene Glycols) RN - 80168379AG (Doxorubicin) MH - Adult MH - Antiretroviral Therapy, Highly Active/*adverse effects MH - Chylous Ascites/*diagnostic imaging MH - Diagnosis, Differential MH - Doxorubicin/administration & dosage/analogs & derivatives/therapeutic use MH - HIV Infections/complications/diagnosis/*drug therapy MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/diagnostic imaging MH - Male MH - Polyethylene Glycols/administration & dosage/therapeutic use MH - Prognosis MH - Sarcoma, Kaposi/*complications/drug therapy/etiology MH - Sexual and Gender Minorities MH - Tomography, X-Ray Computed PMC - PMC6510130 OTO - NOTNLM OT - HIV/aids OT - haematology (incl blood transfusion) COIS- Competing interests: None declared. EDAT- 2019/03/25 06:00 MHDA- 2019/07/25 06:00 PMCR- 2021/03/22 CRDT- 2019/03/25 06:00 PHST- 2019/03/25 06:00 [entrez] PHST- 2019/03/25 06:00 [pubmed] PHST- 2019/07/25 06:00 [medline] PHST- 2021/03/22 00:00 [pmc-release] AID - 12/3/e228406 [pii] AID - bcr-2018-228406 [pii] AID - 10.1136/bcr-2018-228406 [doi] PST - epublish SO - BMJ Case Rep. 2019 Mar 22;12(3):e228406. doi: 10.1136/bcr-2018-228406.